Short Interest in Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Expands By 185.7%

Reckitt Benckiser Group plc (OTCMKTS:RBGLY) saw a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 22,000 shares, a growth of 185.7% from the March 31st total of 7,700 shares. Based on an average daily volume of 3,178,000 shares, the days-to-cover ratio is currently 0.0 days.

Wall Street Analysts Forecast Growth

Separately, BNP Paribas upgraded Reckitt Benckiser Group from an “underperform” rating to a “neutral” rating in a report on Tuesday, January 9th. One analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $6,978.00.

Reckitt Benckiser Group Stock Performance

Shares of RBGLY stock opened at $11.00 on Friday. Reckitt Benckiser Group has a 1-year low of $10.24 and a 1-year high of $16.60. The stock’s fifty day moving average price is $12.00 and its 200 day moving average price is $13.26.

Reckitt Benckiser Group Increases Dividend

The firm also recently announced a dividend, which will be paid on Monday, June 3rd. Investors of record on Friday, April 12th will be paid a dividend of $0.2701 per share. This is an increase from Reckitt Benckiser Group’s previous dividend of $0.18. The ex-dividend date of this dividend is Thursday, April 11th.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.